Back
Lucid Diagnostics Stock Price Chart

From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
31
LUCD
Lucid Diagnostics
Last Price:
$1.28
Seasonality Move:
-1.87%
7 Day Trial
ALL ACCESS PASS
$
7

Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LUCD is experiencing slight buying pressure.
Lucid Diagnostics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.3 | Sell |
20-day SMA: | 1.32 | Sell |
50-day SMA: | 1.32 | Sell |
200-day SMA: | 1.07 | Buy |
8-day EMA: | 1.3 | Buy |
20-day EMA: | 1.31 | Sell |
50-day EMA: | 1.31 | Sell |
200-day EMA: | 1.16 | Buy |
Lucid Diagnostics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.09 | Sell |
Chaikin Money Flow: | 50565 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.17 - 1.41) | Buy |
Bollinger Bands (100): | (1.07 - 1.49) | Buy |
Lucid Diagnostics Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Lucid Diagnostics Stock
Is Lucid Diagnostics Stock a Buy?
-
Lucid Diagnostics share price is 1.30 while LUCD 8-day simple moving average is 1.30, which is a Sell signal.
-
The stock price of LUCD is 1.30 while Lucid Diagnostics 20-day SMA is 1.32, which makes it a Sell.
-
Lucid Diagnostics 50-day simple moving average is 1.32 while LUCD share price is 1.30, making it a Sell technically.
-
LUCD stock price is 1.30 and Lucid Diagnostics 200-day simple moving average is 1.07, creating a Buy signal.
LUCD Technical Analysis vs Fundamental Analysis
Sell
31
Lucid Diagnostics (LUCD)
is a Sell
Is Lucid Diagnostics a Buy or a Sell?
-
Lucid Diagnostics stock is rated a SellThe current Lucid Diagnostics [LUCD] share price is $1.30. The Score for LUCD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Lucid Diagnostics Stock Info
Market Cap:
132.1M
Price in USD:
1.30
Share Volume:
859.6K
Lucid Diagnostics 52-Week Range
52-Week High:
1.80
52-Week Low:
0.68
Sell
31
Lucid Diagnostics (LUCD)
is a Sell
Lucid Diagnostics Share Price Forecast
-
What is the Lucid Diagnostics stock price today?The Lucid Diagnostics stock price is 1.30 USD today.
-
Will LUCD stock go up or go down?Lucid Diagnostics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lucid Diagnostics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lucid Diagnostics is overvalued.
Is Lucid Diagnostics Stock a Buy?
-
Lucid Diagnostics share price is 1.30 while LUCD 8-day exponential moving average is 1.30, which is a Buy signal.
-
The stock price of LUCD is 1.30 while Lucid Diagnostics 20-day EMA is 1.31, which makes it a Sell.
-
Lucid Diagnostics 50-day exponential moving average is 1.31 while LUCD share price is 1.30, making it a Sell technically.
-
LUCD stock price is 1.30 and Lucid Diagnostics 200-day simple moving average is 1.16, creating a Buy signal.
Fundamental Analysis of Lucid Diagnostics
Is Lucid Diagnostics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.32 per share, and an increase next year of $0.12 per share.
Technical Analysis of Lucid Diagnostics
Should I short Lucid Diagnostics stock?
-
LUCD Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Lucid Diagnostics is a Sell
-
Lucid Diagnostics Relative Strength Index (RSI) is 49.09, which suggest Lucid Diagnostics is oversold
-
The Bollinger Bands (25) for Lucid Diagnostics is (1.17 - 1.41), which suggest Lucid Diagnostics is a Buy
-
The Bollinger Bands (100) for Lucid Diagnostics is (1.07 - 1.49), which suggest Lucid Diagnostics is a Buy
* Lucid Diagnostics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.